These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
150 related articles for article (PubMed ID: 7306680)
1. Carcinogen binding to DNA. Straub KM; Burlingame AL Biomed Mass Spectrom; 1981 Sep; 8(9):431-5. PubMed ID: 7306680 [TBL] [Abstract][Full Text] [Related]
2. Environmental and chemical carcinogenesis. Wogan GN; Hecht SS; Felton JS; Conney AH; Loeb LA Semin Cancer Biol; 2004 Dec; 14(6):473-86. PubMed ID: 15489140 [TBL] [Abstract][Full Text] [Related]
3. Mass spectrometric analysis of relative levels of pyridyloxobutylation adducts formed in the reaction of DNA with a chemically activated form of the tobacco-specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone. Sturla SJ; Scott J; Lao Y; Hecht SS; Villalta PW Chem Res Toxicol; 2005 Jun; 18(6):1048-55. PubMed ID: 15962940 [TBL] [Abstract][Full Text] [Related]
4. A comparison of the carcinogen-DNA adducts formed in rat liver in vivo after administration of single or multiple doses of N-methyl-4-aminoazobenzene. Tillis DL; Straub KM; Kadlubar FF Chem Biol Interact; 1981 Dec; 38(1):15-27. PubMed ID: 7326805 [TBL] [Abstract][Full Text] [Related]
5. Searches for ultimate chemical carcinogens and their reactions with cellular macromolecules. Miller EC; Miller JA Cancer; 1981 May; 47(10):2327-45. PubMed ID: 7272889 [TBL] [Abstract][Full Text] [Related]
6. Constitutive and carcinogen-derived DNA binding as a basis for the assessment of potency of chemical carcinogens. Lutz WK Adv Exp Med Biol; 1981; 136 Pt B():1349-65. PubMed ID: 7344514 [TBL] [Abstract][Full Text] [Related]
7. Advantages and limitations of laboratory methods for measurement of carcinogen-DNA adducts for epidemiological studies. Kaderlik RK; Lin DX; Lang NP; Kadlubar FF Toxicol Lett; 1992 Dec; 64-65 Spec No():469-75. PubMed ID: 1471199 [TBL] [Abstract][Full Text] [Related]
8. Novel uses of mass spectrometry in studies of adducts of alkylating agents with nucleic acids and proteins. Farmer PB; Lamb J; Lawley PD IARC Sci Publ; 1988; (89):347-55. PubMed ID: 3198219 [TBL] [Abstract][Full Text] [Related]
9. Structural characteristics of compounds that can be activated to chemically reactive metabolites: use for a prediction of a carcinogenic potential. Lutz WK Arch Toxicol Suppl; 1984; 7():194-207. PubMed ID: 6595983 [TBL] [Abstract][Full Text] [Related]
10. 32P-postlabelling and mass spectrometric methods for analysis of bulky, polyaromatic carcinogen-DNA adducts in humans. Talaska G; Roh JH; Getek T J Chromatogr; 1992 Sep; 580(1-2):293-323. PubMed ID: 1400827 [TBL] [Abstract][Full Text] [Related]
11. Carcinogen-macromolecular adducts as biomarkers in human cancer risk assessment. Hsia MT Biomed Environ Sci; 1991 Jun; 4(1-2):104-12. PubMed ID: 1910588 [TBL] [Abstract][Full Text] [Related]
12. Identification of C8-modified deoxyinosine and N2- and C8-modified deoxyguanosine as major products of the in vitro reaction of N-hydroxy-6-aminochrysene with DNA and the formation of these adducts in isolated rat hepatocytes treated with 6-nitrochrysene and 6-aminochrysene. Delclos KB; Miller DW; Lay JO; Casciano DA; Walker RP; Fu PP; Kadlubar FF Carcinogenesis; 1987 Nov; 8(11):1703-9. PubMed ID: 3664962 [TBL] [Abstract][Full Text] [Related]
13. Carcinogen macromolecular adducts and their measurement. Poirier MC; Santella RM; Weston A Carcinogenesis; 2000 Mar; 21(3):353-9. PubMed ID: 10688855 [TBL] [Abstract][Full Text] [Related]
14. One-electron oxidation is not a major route of metabolic activation and DNA binding for the carcinogen 7H-dibenzo[c,g]carbazole in vitro and in mouse liver and lung. Dowty HV; Xue W; LaDow K; Talaska G; Warshawsky D Carcinogenesis; 2000 May; 21(5):991-8. PubMed ID: 10783323 [TBL] [Abstract][Full Text] [Related]
15. DNA adducts and the mechanism of carcinogenesis and cytotoxicity of methylating agents of environmental and clinical significance. Kyrtopoulos SA; Anderson LM; Chhabra SK; Souliotis VL; Pletsa V; Valavanis C; Georgiadis P Cancer Detect Prev; 1997; 21(5):391-405. PubMed ID: 9307842 [TBL] [Abstract][Full Text] [Related]
16. Carcinogen adducts as an indicator for the public health risks of consuming carcinogen-exposed fish and shellfish. Dunn BP Environ Health Perspect; 1991 Jan; 90():111-6. PubMed ID: 2050048 [TBL] [Abstract][Full Text] [Related]
17. Monitoring carcinogen actions on DNA by 32P-postlabeling. Randerath K; Randerath E Princess Takamatsu Symp; 1990; 21():317-28. PubMed ID: 2134685 [TBL] [Abstract][Full Text] [Related]
18. Carcinogen-nucleic acid interactions: equilibrium binding studies of aflatoxins B1 and B2 with DNA and the oligodeoxynucleotide d(ATGCAT)2. Stone MP; Gopalakrishnan S; Harris TM; Graves DE J Biomol Struct Dyn; 1988 Apr; 5(5):1025-41. PubMed ID: 3152158 [TBL] [Abstract][Full Text] [Related]
19. The uses of carcinogen-DNA adduct measurement in establishing mechanisms of mutagenesis and in chemoprevention. Baird WM; Mahadevan B Mutat Res; 2004 Mar; 547(1-2):1-4. PubMed ID: 15013693 [TBL] [Abstract][Full Text] [Related]
20. Carcinogen-DNA adducts as tools in risk assessment. Airoldi L; Pastorelli R; Magagnotti C; Fanelli R Adv Exp Med Biol; 1999; 472():231-40. PubMed ID: 10736630 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]